| dc.contributor.author | KARALOGLU, D | |
| dc.contributor.author | Yasasever, V | |
| dc.contributor.author | DALAY, N | |
| dc.contributor.author | CAMLICA, Hakan | |
| dc.contributor.author | DINCER, M | |
| dc.date.accessioned | 2021-03-06T11:00:25Z | |
| dc.date.available | 2021-03-06T11:00:25Z | |
| dc.date.issued | 1997 | |
| dc.identifier.citation | Yasasever V., DINCER M., CAMLICA H., KARALOGLU D., DALAY N., "Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena", CLINICAL BIOCHEMISTRY, cilt.30, ss.53-56, 1997 | |
| dc.identifier.issn | 0009-9120 | |
| dc.identifier.other | av_ed1a91a7-6860-4fcc-a96d-be772e8e9e00 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/155638 | |
| dc.identifier.uri | https://doi.org/10.1016/s0009-9120(96)00133-6 | |
| dc.description.abstract | Objectives: CA 15-3 and CEA are considered useful tumor markers in monitoring breast cancer patients. This study was undertaken to specifically evaluate the transient elevations in these markers that are observed during systemic treatment for metastatic disease. This phenomenon has been termed ''spiking.'' | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Tıp | |
| dc.title | Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena | |
| dc.type | Makale | |
| dc.relation.journal | CLINICAL BIOCHEMISTRY | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 30 | |
| dc.identifier.issue | 1 | |
| dc.identifier.startpage | 53 | |
| dc.identifier.endpage | 56 | |
| dc.contributor.firstauthorID | 7458 | |
